Abstract
Bone marrow-derived mesenchymal stem cells (MSCs) colonize wounds apparently to facilitate tissue regeneration. Remarkably, they are able to differentiate into cells that are specifically needed to repair the injured tissue. However, MSCs are also attracted to cancers, likely because MSCs mistake cancers for wounds, and may there influence the proliferative and metastatic activities of the cancer cells. Recently, it was demonstrated that MSCs increase the motility of breast cancer cells by activating ADAM10, a protease which regulates epithelial cell-cell adhesion and which is often overexpressed in cancer. By targeting ADAM10 MSCs may promote progression of breast cancer. Cancers may mislead MSCs and use them for their own 'needs.'
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
